Search results 41 until 50 of 800
800 results:

Partners join forces to improve lives of millions of Parkinson’s patients worldwide with a transformative technology-based solution Gerresheimer participates in seed-round of the Finnish MedTech…
Learn more
Test für Startseite
Learn more
Duesseldorf, June 08, 2022 – The Annual General Meeting of Gerresheimer AG has approved the payment of a dividend of EUR 1.25 per share for the 2021 financial year. This represents a payout ratio of…
Learn more
Best-in-class Gx® Elite Glass Vials Reduced filling line breakage and product rejects The Gx® Elite vials are the result of a careful product development process spanning several years. The highly…
Learn more
All products Round bottles Oval bottles Rectangular bottles Square bottles Special bottles Roll-on bottles Cream Jars Dropper bottles Cosmetic ampoules Perfume samplers …
Learn more
Gerresheimer Glass Inc. (Vineland Headquarters) Headquarters 537 Crystal Avenue Vineland, NJ 08360 USA Phone: +1 856-692-3600  E-Mail: info-tg-us@gerresheimer.com Routing Vineland…
Learn more
Platform Solutions Gerresheimer offers innovative platform solutions that accelerate the cost-efficient development of medical devices. From concept to delivery of the final product - One-Stop-Shop…
Learn more
Services We offer Laboratory and Regulatory Affairs Services.
Learn more
Gerresheimer auto-injector for biological drugs and small molecules The auto-injector is the innovative result of the strategic partnership between Gerresheimer and Midas Pharma. Having acquired…
Learn more
Wackersdorf, May 30, 2022: The drug development company ISR has signed an agreement with Gerresheimer for large-scale production of the IcoOne nasal inhaler, for its phase III study of its dry…
Learn more
Search results 41 until 50 of 800

Contact us!

Do you have any questions? We are happy to help you!

Phone: +49 211 61 81 - 00

Contact Form

Contact jobs & career